April 25, 2019
BONESUPPORT HOLDING AB (publ) – Q1 2019 Interim Report – invitation to conference call and webcast
Media
April 25, 2019
GenSight Biologics announces presentation of 72-week data from the REVERSE & RESCUE Phase III trials of GS010 at the Annual Meeting of ARVO
April 24, 2019
Oncopeptides provides new guidance on the patient recruitment in the OCEAN study and a clinical program update in a webcast at 10:00 (CET)
April 24, 2019
GenSight Biologics Reports Full Year 2018 Financial Results
April 23, 2019
Vicore Pharma announces systemic sclerosis as the second indication for VP01
April 18, 2019
BONESUPPORT HOLDING AB (publ) publishes Annual Report 2018
April 17, 2019
GenSight Biologics reports positive follow-up results at Week 72 of the RESCUE Phase III clinical trial of GS010 in Leber Hereditary Optic Neuropathy (LHON)
April 16, 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
April 15, 2019
Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2019 American Association of Clinical Endocrinologists (AACE) Annual
April 12, 2019
Vicore Pharma’s Annual Report 2018 published
